Ken Griffin Health Sciences Acquisitions Corp 2 Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$9.85 - $10.0 $13,297 - $13,500	-1,350 Reduced 0.79%	170,458 $1.7 Million
Q3 2022 Nov 14, 2022	SELL	$9.8 - $10.02 $775,768 - $793,183	-79,160 Reduced 31.54%	171,808 $1.7 Million
Q2 2022 Aug 15, 2022	SELL	$9.9 - $9.98 $105,197 - $106,047	-10,626 Reduced 4.06%	250,968 $2.5 Million
Q1 2022 May 16, 2022	SELL	$9.82 - $9.92 $16,566 - $16,735	-1,687 Reduced 0.64%	261,594 $2.59 Million
Q4 2021 Feb 14, 2022	BUY	$9.81 - $10.08 $33,913 - $34,846	3,457 Added 1.33%	263,281 $2.65 Million
Q3 2021 Nov 15, 2021	BUY	$9.74 - $10.05 $42,709 - $44,069	4,385 Added 1.72%	259,824 $2.57 Million
Q2 2021 Aug 16, 2021	SELL	$9.97 - $11.16 $36,400 - $40,745	-3,651 Reduced 1.41%	255,439 $2.61 Million
Q1 2021 May 17, 2021	BUY	$10.21 - $14.46 $92,808 - $131,441	9,090 Added 3.64%	259,090 $2.91 Million
Q3 2020 Nov 16, 2020	BUY	$10.84 - $12.39 $2.71 Million - $3.1 Million	250,000 New	250,000 $2.75 Million

Ticker HSAQ
Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Shares Outstandng 11,212,100
Description
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Science...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.